Congratulations Dave Segal

Exciting News!

We are proud to share that David Segal has been named a 2025 Oxford-Harrington Rare Disease Centre Scholar. This prestigious recognition supports groundbreaking work in rare disease research and innovation.

As part of the program, each Scholar will receive:

An advisory team providing advanced drug and business development support
$100,000 in funding
The opportunity to compete for additional advisory support and acceleration funds
Eligibility to qualify for investment funds of up to $1,000,000, based on project requirements
Congratulations to David on this incredible achievement!